Vandetanib increases the efficacy of tamoxifen in a preclinical luminal breast cancer model

Abstract

Philip Spanheimer, Jung M. Park, Ryan W. Askeland, Anthony R. Cyr, George W. Woodfield and Ronald J. Weigel

Journal of the American College of Surgeons, Vol.217(3), pp.S127-S127

09/2013

DOI: 10.1016/j.jamcollsurg.2013.07.293

View Online

Title: Subtitle: Vandetanib increases the efficacy of tamoxifen in a preclinical luminal breast cancer model
Creators: Philip Spanheimer
Jung M. Park
Ryan W. Askeland
Anthony R. Cyr
George W. Woodfield
Ronald J. Weigel
Resource Type: Abstract
Publication Details: Journal of the American College of Surgeons, Vol.217(3), pp.S127-S127
DOI: 10.1016/j.jamcollsurg.2013.07.293
ISSN: 1072-7515
eISSN: 1879-1190
Language: English
Date published: 09/2013
Academic Unit: Molecular Physiology and Biophysics; Anatomy and Cell Biology; Surgery; Biochemistry and Molecular Biology
Record Identifier: 9984288755902771

2 Record Views